HOLSTON MEDICAL GROUP WILL PARTICIPATE IN COVID-19 VACCINE TRIAL

Holston Medical Group will participate in a global study for a COVID-19 vaccine trial. HMG says that they need 250 participants for each of the Kingsport and Bristol locations. Since this is a controlled study, half of the participants will receive the vaccine, while the other half will get a placebo. At the beginning, participants will not know which group they are in, but they will eventually find out during the study. Participants must be in good health, between 18-and 85-years old who have contact with people. More than 30,000 participants are combined the worldwide COVID-19 vaccine study sponsored by Pfizer and Biontech. Participants can expect to receive an injection on the first day of the study and another about three weeks into the study. The study will last two years. HMG has conducted over 800 clinical trials since the late 1990's, so we have a lot of experience in this field.

---